Some community reports mention localized injection-site warmth in animal models, though this is not systematically documented in peer-reviewed studies
Semaglutide (Wegovy and Ozempic): Weekly GLP-1 injection Semaglutide is an FDA-approved GLP-1 receptor agonist that mimics the activity of the natural hormone GLP-1, which regulates hunger and appetite
Dosage and Administration: For Parenteral Use Only after dilution or dissolution of compatible drugs, following manufacturer instructions: Do Not Use Directly : Not suitable for direct IV, IM, or SC injection without first being mixed with a solute
Furthermore, discard any vials showing visible particulates, cloudiness, or discoloration before use
So, which one is best
The studies tested various doses including 0.25 mg, 0.5 mg, and 1 mg daily via subcutaneous administration over periods ranging from single doses to 24 weeks of continuous therapy